Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuyan Xu

Showing results (61-70 of 86) with videos related to

Pageof 9
Sort By:
Journal of Hepatocellular Carcinoma|April 20, 2026
Development and Validation of Predictive Machine Learning Models for Postoperative Recurrence and Microvascular Invasion in Hepatocellular Carcinoma Using Nuclear Magnetic Resonance MetabolomicsHongkun Tan, Yuyan Xu, Wenxuan Liu, et al.
Fundamental Research|June 27, 2024
Rare and undiagnosed diseases: From disease-causing gene identification to mechanism elucidationGang Wang, Yuyan Xu, Qintao Wang, et al.
Chemical Communications (Cambridge, England)|June 6, 2025
MoS<sub>2</sub>/CoS<sub>2</sub> heterostructures as a thermoelectric-catalyst for H<sub>2</sub>O<sub>2</sub> generation under a small temperature gradientJohnson Mary Leeda Rani Abisharani, Yangyang Wan, Qian Yu, et al.
Natural Product Research|February 19, 2025
Phenolic constituents from the roots of <i>Strobilanthes sarcorrhiza</i> C. Ling and their bioactivityMingjie Xu, Yiwei Wu, Taohong Han, et al.
Brain Research|July 17, 2024
Inhibiting NF-κB inducing kinase improved the motor performance of ALS animal modelMengjie Cao, Le Yi, Yuyan Xu, et al.
Frontiers in Immunology|September 19, 2022
Case report: Primary hepatocellular carcinoma with portal vein tumor thrombus characterized by active tumor immune microenvironment achieving a complete response following treatment of combined immunotherapyKaihang Zhong, Yuyan Xu, Yuan Cheng, et al.
Nature Communications|September 18, 2023
Metabolic Reprogramming via ACOD1 depletion enhances function of human induced pluripotent stem cell-derived CAR-macrophages in solid tumorsXudong Wang, Siyu Su, Yuqing Zhu, et al.
American Journal of Cancer Research|February 1, 2021
Epigenetically silenced linc00261 contributes to the metastasis of hepatocellular carcinoma via inducing the deficiency of FOXA2 transcriptionZhanjun Chen, Leyang Xiang, Zhigang Hu, et al.
Cancer Reports (Hoboken, N.J.)|September 15, 2025
Identification of Tumor Antigens and Immune Subtypes in Hepatocellular Carcinoma From a Multiomics PerspectiveChunming Wang, Lei Cai, Qingyu Xie, et al.
Scientific Reports|July 2, 2025
Efficacy of combined TAE, HAIC, targeted, and immunotherapy in unresectable HCC: a multicenter propensity score matching studyCheng Zhang, Yuyan Xu, Lei Cai, et al.
Pageof 9

Showing results (61-70 of 86) with videos related to

Sort By:
Pageof 9
Journal of Hepatocellular Carcinoma|April 20, 2026
Development and Validation of Predictive Machine Learning Models for Postoperative Recurrence and Microvascular Invasion in Hepatocellular Carcinoma Using Nuclear Magnetic Resonance MetabolomicsHongkun Tan, Yuyan Xu, Wenxuan Liu, et al.
Fundamental Research|June 27, 2024
Rare and undiagnosed diseases: From disease-causing gene identification to mechanism elucidationGang Wang, Yuyan Xu, Qintao Wang, et al.
Chemical Communications (Cambridge, England)|June 6, 2025
MoS<sub>2</sub>/CoS<sub>2</sub> heterostructures as a thermoelectric-catalyst for H<sub>2</sub>O<sub>2</sub> generation under a small temperature gradientJohnson Mary Leeda Rani Abisharani, Yangyang Wan, Qian Yu, et al.
Natural Product Research|February 19, 2025
Phenolic constituents from the roots of <i>Strobilanthes sarcorrhiza</i> C. Ling and their bioactivityMingjie Xu, Yiwei Wu, Taohong Han, et al.
Brain Research|July 17, 2024
Inhibiting NF-κB inducing kinase improved the motor performance of ALS animal modelMengjie Cao, Le Yi, Yuyan Xu, et al.
Frontiers in Immunology|September 19, 2022
Case report: Primary hepatocellular carcinoma with portal vein tumor thrombus characterized by active tumor immune microenvironment achieving a complete response following treatment of combined immunotherapyKaihang Zhong, Yuyan Xu, Yuan Cheng, et al.
Nature Communications|September 18, 2023
Metabolic Reprogramming via ACOD1 depletion enhances function of human induced pluripotent stem cell-derived CAR-macrophages in solid tumorsXudong Wang, Siyu Su, Yuqing Zhu, et al.
American Journal of Cancer Research|February 1, 2021
Epigenetically silenced linc00261 contributes to the metastasis of hepatocellular carcinoma via inducing the deficiency of FOXA2 transcriptionZhanjun Chen, Leyang Xiang, Zhigang Hu, et al.
Cancer Reports (Hoboken, N.J.)|September 15, 2025
Identification of Tumor Antigens and Immune Subtypes in Hepatocellular Carcinoma From a Multiomics PerspectiveChunming Wang, Lei Cai, Qingyu Xie, et al.
Scientific Reports|July 2, 2025
Efficacy of combined TAE, HAIC, targeted, and immunotherapy in unresectable HCC: a multicenter propensity score matching studyCheng Zhang, Yuyan Xu, Lei Cai, et al.
Pageof 9